NCT05260957
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Miami Miami, Florida, United States
Clinical trial condition
Aggressive Non-Hodgkin Lymphoma
Explore clinical trials studying Aggressive Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.
14 public trials
1 recruiting study
Aggressive Non-Hodgkin Lymphoma trial results
Active, not recruiting
Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma
NCT04231877
- Conditions
- ALK-Positive Large B-Cell Lymphoma, Aggressive Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, not recruiting
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
NCT01787409
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +40 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
- Mayo Clinic Rochester, Minnesota, United States
Active, not recruiting
Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
NCT03749018
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma, +22 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT03035331
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Chronic Disease, Disease Attributes, +31 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT01231412
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
- Locations
-
- University of Colorado Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
NCT03458260
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- AZ Sint Jan Bruges, Belgium
- Institut Jules Bordet - Centre des tumeurs de l'ULB Brussels, Belgium
- Centre Hospitalier de Jolimont Haine-Saint-Paul, Belgium
- CH d'Avignon Avignon, France
Completed
Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma
NCT03061188
- Conditions
- Advanced Solid Neoplasm, Aggressive Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
NCT03161054
- Conditions
- Aggressive Non-Hodgkin Lymphoma
- Locations
-
- A.O. Spedali Civili di Brescia - Ematologia Brescia, Italy
- Ospedale di Castelfranco Veneto - Ematologia Castelfranco Veneto, Italy
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) - Ematologia Meldola, Italy
- Ospedale Guglielmo da Saliceto - U.O.Ematologia Piacenza, Italy
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +49 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
- Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States
- Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States